IFS
CRL icon

Ifrah Financial Services’s Charles River Laboratories CRL Stock Holding History

Ifrah Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-661
Closed -$249K – 225
2021
Q4 		$249K Buy
661
+4
+0.6% +$1.55K 0.07% 189
2021
Q3 		$271K Sell
657
-4
-0.6% -$1.66K 0.08% 168
2021
Q2 		$244K Buy
+661
New +$221K 0.07% 184

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ifrah Financial Services's CRL Position: Q1 2022 in Review

Ifrah Financial Services sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 661 shares — an estimated $249K sold.

Ifrah Financial Services first reported a position in CRL in Q2 2021 and held it in 3 quarters. The position peaked at $271K in Q3 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Ifrah Financial Services reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Ifrah Financial Services sold 661 Charles River Laboratories shares in Q1 2022, an estimated $249K.
  • Ifrah Financial Services first reported a position in Charles River Laboratories in Q2 2021 and held it in 3 quarters.
  • Ifrah Financial Services's Charles River Laboratories position peaked at $271K in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Ifrah Financial Services's 13F filing for Q1 2022, filed 3 May 2022.